采用高效液相色谱法验证的时间杀菌法测定伏立康唑对白色念珠菌、光滑念珠菌和近平滑念珠菌分离株的活性。
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
作者信息
Li Yanjun, Nguyen M Hong, Derendorf Hartmut, Cheng Shaoji, Clancy Cornelius J
机构信息
Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL 32610, USA.
出版信息
Antimicrob Agents Chemother. 2007 Aug;51(8):2985-7. doi: 10.1128/AAC.00308-07. Epub 2007 May 21.
Abstract
We developed a high-performance liquid chromatography (HPLC) assay to validate time-kill and postantifungal-effect (PAFE) experiments for voriconazole against Candida albicans, Candida glabrata, and Candida parapsilosis isolates. Voriconazole exerted prolonged fungistatic activity but no PAFE at concentrations achievable in human sera. HPLC confirmed that experiments were conducted at the desired steady-state voriconazole concentrations.
摘要
我们开发了一种高效液相色谱（HPLC）分析法，以验证伏立康唑针对白色念珠菌、光滑念珠菌和近平滑念珠菌分离株的时间杀菌和抗真菌后效应（PAFE）实验。在人血清可达到的浓度下，伏立康唑具有延长的抑菌活性，但无PAFE。HPLC证实实验是在所需的伏立康唑稳态浓度下进行的。
相似文献
1
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
Antimicrob Agents Chemother. 2007 Aug;51(8):2985-7. doi: 10.1128/AAC.00308-07. Epub 2007 May 21.
2
Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
Antimicrob Agents Chemother. 2006 Jul;50(7):2569-72. doi: 10.1128/AAC.00291-06.
3
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):592-5. doi: 10.1007/s10096-005-0005-y.
4
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
J Clin Microbiol. 2009 Jun;47(6):1927-30. doi: 10.1128/JCM.02070-08. Epub 2009 Apr 29.
5
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Int J Antimicrob Agents. 2008 Mar;31(3):266-71. doi: 10.1016/j.ijantimicag.2007.09.010. Epub 2007 Dec 3.
6
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
Int J Antimicrob Agents. 2009 Sep;34(3):240-5. doi: 10.1016/j.ijantimicag.2009.02.006. Epub 2009 Mar 31.
7
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Diagn Microbiol Infect Dis. 2008 Oct;62(2):177-81. doi: 10.1016/j.diagmicrobio.2008.07.001. Epub 2008 Aug 8.
8
Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.
J Clin Microbiol. 2000 Oct;38(10):3715-7. doi: 10.1128/JCM.38.10.3715-3717.2000.
9
In vitro activity of voriconazole against Candida species isolated in Taiwan.
Int J Antimicrob Agents. 2004 Sep;24(3):294-6. doi: 10.1016/j.ijantimicag.2004.01.014.
10
Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.
Antimicrob Agents Chemother. 2011 Apr;55(4):1794-7. doi: 10.1128/AAC.01757-10. Epub 2011 Jan 31.
引用本文的文献
1
Evaluation of fluconazole, itraconazole, and voriconazole activity on : A case control study.
Ann Med Surg (Lond). 2022 Nov 11;84:104882. doi: 10.1016/j.amsu.2022.104882. eCollection 2022 Dec.
2
Postantifungal Effect of Antifungal Drugs against : What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?
J Fungi (Basel). 2022 Jul 12;8(7):727. doi: 10.3390/jof8070727.
3
Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant and Non- Species.
Infect Dis Obstet Gynecol. 2018 Feb 22;2018:7040498. doi: 10.1155/2018/7040498. eCollection 2018.
4
Effects of antifungal agents in sap activity of Candida albicans isolates.
Mycopathologia. 2010 Feb;169(2):91-8. doi: 10.1007/s11046-009-9232-6. Epub 2009 Aug 15.
5
Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates.
Antimicrob Agents Chemother. 2009 Aug;53(8):3347-52. doi: 10.1128/AAC.01480-08. Epub 2009 Apr 13.
6
A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro.
Int J Antimicrob Agents. 2008 Apr;31(4):369-74. doi: 10.1016/j.ijantimicag.2007.11.015. Epub 2008 Jan 22.
本文引用的文献
1
Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
Antimicrob Agents Chemother. 2006 Jul;50(7):2569-72. doi: 10.1128/AAC.00291-06.
2
Voriconazole therapeutic drug monitoring.
Antimicrob Agents Chemother. 2006 Apr;50(4):1570-2. doi: 10.1128/AAC.50.4.1570-1572.2006.
3
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
J Clin Microbiol. 2006 Mar;44(3):819-26. doi: 10.1128/JCM.44.3.819-826.2006.
4
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
Antimicrob Agents Chemother. 2005 Sep;49(9):3697-701. doi: 10.1128/AAC.49.9.3697-3701.2005.
5
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Antimicrob Agents Chemother. 2005 Apr;49(4):1593-6. doi: 10.1128/AAC.49.4.1593-1596.2005.
6
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Antimicrob Agents Chemother. 2004 Nov;48(11):4453-6. doi: 10.1128/AAC.48.11.4453-4456.2004.
7
8
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Antimicrob Agents Chemother. 2002 Feb;46(2):578-81. doi: 10.1128/AAC.46.2.578-581.2002.
9
Evaluation of voriconazole pharmacodynamics using time-kill methodology.
Antimicrob Agents Chemother. 2000 Jul;44(7):1917-20. doi: 10.1128/AAC.44.7.1917-1920.2000.
10
A rapid HPLC assay for voriconazole in human plasma.
J Pharm Biomed Anal. 1998 Sep;17(8):1449-53. doi: 10.1016/s0731-7085(98)00004-1.
Zotero 插件